| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/03/2000 | EP0563096B1 Novel methylenebisphosphonic acid derivatives |
| 05/03/2000 | EP0559884B1 Viral recombinant vectors for expression in muscle cells |
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | CN1252101A Component of bromelain |
| 05/03/2000 | CN1252096A Component of bromelain |
| 05/03/2000 | CN1252075A Synthetic HIV GAG genes |
| 05/03/2000 | CN1252074A Stimulation of red blood cell production |
| 05/03/2000 | CN1252071A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders |
| 05/03/2000 | CN1252070A 5,7-disubstituted 4-aminopyrido [2,3,-d] pyrimidine compounds and their use as adenosine kinase inhibitors |
| 05/03/2000 | CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds |
| 05/03/2000 | CN1252068A 3-piperidyl-4-oxoquinazoline derivatives and medicinal compositions containing same |
| 05/03/2000 | CN1252064A Bicyclic amino acids |
| 05/03/2000 | CN1252063A 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
| 05/03/2000 | CN1252053A Cetp activity inhibitors |
| 05/03/2000 | CN1252049A 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 05/03/2000 | CN1252006A Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 05/03/2000 | CN1252001A Method for destroying retinal pigment epithelial cells |
| 05/03/2000 | CN1251998A Facililation of wound healing with CM101/GBS toxin |
| 05/03/2000 | CN1251989A Methods and compositions for preventing and treating chronological aging in human skin |
| 05/03/2000 | CN1251763A Process for preparing Chinese medicine 'Qianjin tablets' for treating gynopathy |
| 05/03/2000 | CN1052003C Prodrugs of antiinflammatory 3-acyl-2-oxidole-1-carboxamides |
| 05/03/2000 | CN1051998C Isoquinolines preparation thereof and its medicinal compositions |
| 05/03/2000 | CN1051990C Method for preparing ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
| 05/03/2000 | CN1051921C Methods of inhibiting imperfect tissue repair |
| 05/03/2000 | CN1051919C Depigmenting composition for the simultaneous treatment of surface layers and deep layers of skin, and use thereof |
| 05/02/2000 | US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/02/2000 | US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates |
| 05/02/2000 | US6057445 Formation of carbon nitrogen bond, cyclization and halogenation |
| 05/02/2000 | US6057440 Process for preparing bis-indoly macrocycles |
| 05/02/2000 | US6057437 Antisense nucleic acid compounds inhibiting vascular endothelial growth factor |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057361 Formulations and methods of reducing toxicity of antineoplastic agents |
| 05/02/2000 | US6057349 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 05/02/2000 | US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase |
| 05/02/2000 | US6057345 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 05/02/2000 | US6057341 Bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 05/02/2000 | US6057338 Useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome, pain and diabetic retinopathy |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057332 Substituted 1,4-dihydropyrimidine-5-carboxylate compounds, their preparation and uses |
| 05/02/2000 | US6057326 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 05/02/2000 | US6057325 Have central dopamine and serotonin antogonistic activity |
| 05/02/2000 | US6057321 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 05/02/2000 | US6057318 Heterocyclic derivatives, process for their preparation and their therapeutic use |
| 05/02/2000 | US6057317 Heterocyclic compounds |
| 05/02/2000 | US6057309 Treating osteoporosis |
| 05/02/2000 | US6057295 Oligopeptides derived from C-reactive protein fragments |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |
| 05/02/2000 | US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6057108 Human ARF-related proteins |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2224616C Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 05/02/2000 | CA2069961C Method and compositions for inhibition of disorders associated with oxidative damage |
| 05/02/2000 | CA2047744C Method for the synthesis of huperzine a and analogs thereof and compounds useful therein |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2003009C Method and composition for reducing postsurgical adhesions |
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/28/2000 | CA2287549A1 Antithrombotic agents |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023454A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 04/27/2000 | WO2000023451A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023445A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023443A1 Tetrahydropyridopyridine derivatives and intermediates for producing the same |
| 04/27/2000 | WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | WO2000023426A1 Novel imidazoles with anti-inflammatory activity |
| 04/27/2000 | WO2000023424A1 Epibatidine analogues as acetylcholine receptor antagonists |
| 04/27/2000 | WO2000023417A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023110A1 Methods and agents for inducing apoptosis and methods for their identification |
| 04/27/2000 | WO2000023093A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023088A2 Methods of administering adenoviral vectors |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000023078A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 04/27/2000 | WO2000023076A1 Aminophenoxyacetic acid derivatives as neuroprotectants |
| 04/27/2000 | WO2000023063A2 Methods for inhibiting diabetic complications |
| 04/27/2000 | WO2000023057A2 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
| 04/27/2000 | WO2000023052A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004895A3 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | WO1999061010A3 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |